Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
ImmuCell Corporation
immucell.comAI Executive Summary
AI-powered analysis of 8-K filing content
Steven A. Rosgen resigned from ImmuCell Corporation's Board of Directors effective April 1, 2026, and was replaced by Kathy V. Turner, who brings 30+ years of healthcare and animal health executive experience. This board transition reflects routine governance changes ahead of the company's 2026 Annual Meeting of Shareholders.
Key Takeaways
Steven A. Rosgen opted not to run for reelection and resigned from the Board effective April 1, 2026
Kathy V. Turner was elected to fill the vacancy, bringing over 30 years of global healthcare and animal health executive leadership experience
2 more takeaways
Related Filings (2)
2 more filings from ImmuCell Corporation in the last 90 days